{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NPRC", "heart failure with preserved ejection fraction", "pulmonary hypertension"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32166021", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["2045894020910975", "10.1177/2045894020910975"], "Journal": {"ISSN": "2045-8932", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2020", "Season": "Jan-Mar"}}, "Title": "Pulmonary circulation", "ISOAbbreviation": "Pulm Circ"}, "ArticleTitle": "Role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension.", "Pagination": {"StartPage": "2045894020910975", "MedlinePgn": "2045894020910975"}, "AuthorList": [{"Identifier": ["0000-0001-7142-5477"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Egom Clinical & Translational Research Services Ltd, Toronto, Canada."}], "LastName": "Eroume-A Egom", "ForeName": "Emmanuel", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}], "LastName": "Kamgang", "ForeName": "Rene", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Pulm Circ", "NlmUniqueID": "101557243", "ISSNLinking": "2045-8932"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Agrawal V, Fortune N, Yu S, et al. Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension. Pulmonary circulation 2019; 9: 2045894019878599.", "ArticleIdList": ["PMC6923530", "31903184"]}, {"Citation": "Miller WL, Mahoney DW, Michelena HI, et al. Contribution of ventricular diastolic dysfunction to pulmonary hypertension complicating chronic systolic heart failure. JACC 2011; 4: 946\u2013954.", "ArticleIdList": ["21920331"]}, {"Citation": "Knight DS, Steeden JA, Moledina S, et al. Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study. J Cardiovasc Magn Reson 2015; 17: 116.", "ArticleIdList": ["PMC4696235", "26715551"]}, {"Citation": "Egom EE. Pulmonary arterial hypertension due to NPR-C mutation: a novel paradigm for normal and pathologic remodeling? Int J Mol Sci 2019; 20(12): E3063.", "ArticleIdList": ["PMC6628360", "31234560"]}, {"Citation": "Egom EE, Maher V, El Hiani Y. Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure. Int J Cardiol 2019; 281: 172\u2013178.", "ArticleIdList": ["29885823"]}, {"Citation": "Pereira NL, Redfield MM, Scott C, et al. A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study. PloS One 2014; 9: e85708.", "ArticleIdList": ["PMC3899045", "24465655"]}, {"Citation": "Egom EE, Feridooni T, Pharithi RB, et al. A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: new hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomed Pharmacother 2017; 93: 1144\u20131150.", "ArticleIdList": ["28738523"]}, {"Citation": "Egom EE, Feridooni T, Pharithi RB, et al. Erratum: new insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int J Physiol Pathophysiol Pharmacol 2017; 9: 164.", "ArticleIdList": ["PMC5698694", "29218116"]}, {"Citation": "Egom EE-A, Feridooni T, Pharithi RB, et al. New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int J Physiol Pathophysiol Pharmacol 2017; 9: 112\u2013118.", "ArticleIdList": ["PMC5592245", "28951773"]}, {"Citation": "Gower WR, Jr, Carter GM, McAfee Q, et al. Identification, regulation and anti-proliferative role of the NPR-C receptor in gastric epithelial cells. Mol Cell Biochem 2006; 293: 103\u2013118.", "ArticleIdList": ["16786190"]}, {"Citation": "Jansen HJ, Mackasey M, Moghtadaei M, et al. NPR-C (natriuretic peptide receptor-C) modulates the progression of angiotensin II-mediated atrial fibrillation and atrial remodeling in mice. Circ Arrhythm Electrophysiol 2019; 12: e006863.", "ArticleIdList": ["30636477"]}, {"Citation": "Mackasey M, Egom EE, Jansen HJ, et al. Natriuretic peptide receptor-C protects against angiotensin II-mediated sinoatrial node disease in mice. JACC Basic Transl Sci 2018; 3: 824\u2013843.", "ArticleIdList": ["PMC6314975", "30623142"]}]}], "History": [{"Year": "2020", "Month": "1", "Day": "27"}, {"Year": "2020", "Month": "1", "Day": "29"}, {"Year": "2020", "Month": "3", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["32166021", "PMC7052478", "10.1177/2045894020910975", "10.1177_2045894020910975"]}}]}